Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7

Overview of attention for article published in Neuroscience Bulletin, January 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 1 X user

patent: 4 patents

Readers on

mendeley: 60 Mendeley

Summary X Patents

So far, Altmetric has seen 4 patents that reference this research output.

NOVEL Nav1.7 MONOCLONAL ANTIBODY

Application WO-2023074888-A1

World Intellectual Property Organisation (WIPO)

Rodents having genetically modified sodium channels and methods of use thereof

Grant US-11464217-B2

United States of America

RODENTS HAVING GENETICALLY MODIFIED SODIUM CHANNELS AND METHODS OF USE THEREOF

Application WO-2020172505-A1

World Intellectual Property Organisation (WIPO)

SELECTIVE NAV PROTEIN BINDERS

Application EP-3209693-A2

European Patent Office